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Objectıve: Novel studies which investigated extraskeletal effects of vitamin D
showed that vitamin D plays important role in whole body health, beyond bone health.
Vitamin D receptors are present in various cell types including osteoblasts, car-
diomyocytes, myocytes, endothelium, immune cells and neurons. Vitamin D deﬁ-
ciency is deﬁned as 25-hydroxy D3 values 20 ng/ml and its prevalence varies from
27% to 55% in different series. Decline in systolic and diastolic functions of the heart
has been reported in patients with vitamin D deﬁciency.In this study, we aimed to
investigate short-term effects of vitamin D treatment on systolic and diastolic func-
tions of the heart in patients with vitamin D deﬁciency.
Methods: Fifty patients (3 male/ 47 female, mean age 4612 years) diagnosed as
having vitamin D deﬁciency and osteoporosis were included in this study. All patients
underwent detailed transthoracic echocardiography for evaluation of left ventricular
systolic and diastolic functions of the heart.Oral Vitamin D was administered to all
study paitents for 8 days (a total of 300.000 IU). Transthoracic echocardiography was
repeated for all patients at 30th days.
Results: After one month treatment with oral Vitamin D, serum 25-hydroxy D3 value
increased from 114 ng/ml to 215 ng/ml, p<0.001). After initiation of supple-
mentary vitamin D treatment LVEF (62,65% to 63.8  4, p¼0.025) indicating LV
systolic function improved signiﬁcantly. Also mitral E/A ratio, a measure of diastolic
function, improved signiﬁcantly after treatment with vitamin D treatment (1.160.3 to
1.20.3, p¼0.028). However, IVCT (95.215 to 9613, p¼0.54) and EDEC
(19728 to 19722, p¼0.95) were similar to baseline values. Change in serum
level of vitamin D (6Vit D) was correlated with change in LVEF (6EF, r¼0.39
and p¼0.005) and change in mitral E/A ratio (6E/A, r¼0.340 and p¼0.016).
Linear regression analysis revealed that change in serum 25-hydroxy D3 level
(6Vit D) was signiﬁcantly associated with change in LVEF (6EF) (coefﬁcient-
b¼0.36, p¼0.013).
Conclusıon: Results of this study show that supplementary vitamin D treatment leads
to improvement in LV systolic and diastolic function in patients with vitamin D
deﬁciency, even at short term follow-up. Our results also show that change in Vitamin
D level is signiﬁcantly associated with improvement in LVEF.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTPP-076
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Objectıve: This study includes the results of three years of follow-up data of Melen
study which was designed prospectively in 2010. The present study was designed to
determine major adverse events rates and characteristics after thirty-six moths follow
up of Turkish adults. Also we aimed to evaluate the risk associates of adverse events
and predisposing factors.
Methods: 2298 participants, who joined the study in 2010, were followed. A total of
1495 people were reached via telephone call and included in the study (570 male, 925
female). The individuals were questioned for primary end points of death, ischemic or
hemorrhagic cerebrovascular events, decompensated heart failure, acute coronary
syndrome, hypertensive crisis, arrhythmia, syncope, peripheral vascular disease,
angina attack and hospitalization for non-cardiac reasons.
Results: During thirty-six months follow up, sixteen participants died, fourteen
participants had cerebrovascular events, thirteen were hospitalized with heart failure,
twelve had acute coronary syndrome, thirty-one had hypertensive crisis, eleven had
arrhythmia, thirteen had syncope, two had peripheral vascular disease. A number of 23
participants hospitalized for non-cardiac reasons. The most common cause of non-
cardiac hospitalization was musculoskeletal diseases. Six patients admitted for this
reason. A total of four patients developed cancer.
Conclusıon: Major adverse event rate and correlates were determined in this epide-
miologic study with 4485 participant-year follow-up. Hypertension was the most
common risk factor associated with major adverse events. The results are concordant
with the general concept that hypertension is one of the biggest mortality and
morbidity causes in Turkey.
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Introductıon: Vitamin D and PTH (Parathyroid hormone) are considered important
primarily for calcium and phosporus homeostasis. However, in the recent years,
vitamin D and PTH levels have been linked to cardiovascular disease and mortality.
Materıal and Methods: One hundred patients were included in the study. Patient
group included 50 patients presented to cardiology clinic with ACS (acute coronary
syndrome) and underwent coronary angiography between February 2012 and January
2013. Control group included 50 patients whom coronary angiography revealed
normal coronary arteries in the same time period. In order to minimize the con-
founding effect of seasonal ﬂuctuation of vitamin D levels, we aimed to involve equal
number of patients in each month. Depending of the eligible patients presented, table 1
shows the number of subjects included each month. All blood samples were fasting
morning samples.
Results: 50 patients with ACS (31 male, mean age 57, 2+8, 45) and 50 subjects with
normal coronary arteries (31 male, mean age 54, 56+7, 51) included in the study. The
characteristics of the participants are summarized in table 2. There was no statistically
signiﬁcant difference between the patients with ACS and controls with respect to age,
gender, height, weight, body mass index (BMI) (p> 0.05). Diabetes mellitus,
hyperlipidemia and history of smoking were more common in the patient group. In
the ACS group, 15 (30%) of the patients were diagnosed with anterior myocardial
infarction (MI), 20 (40%) were with inferior MI, 8 (16%) with unstable angina, and
7 (14%) with non- ST elevation MI. 25 (OH) D and corrected calcium levels were
signiﬁcantly lower in patients group (P <0.001) (table 3). Despite there were
higher levels of PTH in the patient group this result did not reach statistical
difference. If 25(OH) levels of 20 considered sufﬁcient, 60% of the control group
and 12% of the patient group had adequate levels of vitamin D.
Dıscussıon: In the recent years, pleiotropic effects of vitamin D has been increasingly
recognized and low 25(OH) vitamin D levels have been tied to hypertension, heart
failure, diabetes mellitus, coronary artery disease, stroke and mortality in numerous
epidemiologic, observational and experimental studies. Similar to vitamin D, PTH
which is a regulator hormone in mineral homeostasis, affects vascular smooth muscle
and endothelium and heart besides bone and kidney, and has been associated with
hypertension, heart failure and coronary heart disease.
Conclusıon: Vitamin D and corrected calcium levels were signiﬁcantly lower in
patients with ACS compared with patients with normal coronary arteries independent
of seasonal ﬂuctuation. PTH levels were higher in ACS group; however, this result
was not statistically signiﬁcant. Further studies with a larger number of patients are
warranted to conﬁrm our results.ERS C111
